前列腺癌中的T细胞激活疗法:分子洞察免疫疗法的新前沿
Whi-An Kwon1, Jae Young Joung2
1Department of Urology, Hanyang University College of Medicine, Myongji Hospital, Goyang 10475, Republic of Korea.
Cancers
|June 13, 2025
概括
通过将T细胞与癌细胞联系起来,T细胞吸引剂 (TCE) 对晚期前列腺癌具有前途. 针对性和设计方面的创新正在改善反应,但毒性和抗原逃逸等挑战仍然存在.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子工程分子工程分子工程
背景情况:
- 晚期前列腺癌 (PCa) 的治疗选择有限,免疫检查点抑制剂由于"免疫感冒"的微环境而显示出最小的疗效.
- T细胞参与剂 (TCE),针对T细胞上的CD3的双特异性抗体和瘤相关抗原 (TAA),对PCa具有强大的,MHC独立的细胞毒性.
- 早期针对PSMA的TCE证明了概念验证,而针对STEAP1的新代理显示了增强的客观反应,表明目标选择和分子设计的进展.
研究的目的:
- 审查目前针对前列腺癌中PSMA,STEAP1和DLL3的TCE的现状.
- 批判性地评估新出现的临床证据,并确定PCa中TCE治疗的关键挑战和未来方向.
- 将分子工程的进步与临床结果和治疗潜力联系起来.
主要方法:
- 文献综述和新兴临床数据的合成TCEs在晚期前列腺癌.
- 对分子工程策略的批判性评估,包括亲和度调整,掩盖和多种特异构造.
- 讨论减轻毒性,基于生物标志物的患者选择和组合治疗方法.
主要成果:
- 与之前的PSMA向药物相比,像Xaluritamig这样的STEAP1向的TCE显示出更实质的客观反应.
- 对于TCE的关键挑战包括细胞因子释放综合征 (CRS),有限的反应耐久性和抗原逃逸.
- 复杂的工程和组合疗法对于克服抵抗机制和提高疗效至关重要.
结论:
- TCE正在成为晚期前列腺癌的重要治疗支柱,提供强大的抗瘤活性.
- 通过创新的工程和战略组合,克服与安全性,耐用性和抗原逃逸有关的挑战,对于实现TCE的全部潜力至关重要.
- 基于生物标志物的患者选择和与现有治疗方法的整合对于优化PCa中TCE治疗结果至关重要.
关键词:
在 DLL3 中,你会看到 DLL3 文件.在PSMA上,PSMA可以在PSMA上进行交易.第一个步骤: STEP1参与T细胞参与者 (TCE)两种特异性抗体的抗体组合疗法治疗组合治疗.细胞因子释放综合征 (CRS)免疫疗法 免疫疗法分子工程 分子工程是指分子工程.前列腺癌是前列腺癌.更多相关视频
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
306
11:56In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
Published on: May 15, 2014
9.1K
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K